Q32 Bio Inc.QTTBNASDAQ
LOADING
|||
R&D Expense Growth Trend
Trending higher.
Left:
||||
Year-over-year research & development expense growth
Latest
51.73%
Near historical average
Average (8y)
52.22%
Historical baseline
Range
High:275.38%
Low:-61.53%
Volatility
645.2%
High variability
| Period | Value |
|---|---|
| 2024 | 51.73% |
| 2023 | -11.41% |
| 2022 | -61.53% |
| 2021 | -7.28% |
| 2020 | 12.30% |
| 2019 | 86.45% |
| 2018 | 124.29% |
| 2017 | 275.38% |
| 2016 | 0.00% |